84
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Impact of Opioid Receptor Gene Polymorphism on Fentanyl and Alfentanil’s Analgesic Effects in the Pediatric Perioperative Period

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , , & ORCID Icon show all
Pages 41-49 | Received 03 Oct 2023, Accepted 18 Jan 2024, Published online: 29 Jan 2024

References

  • Ziesenitz VC, Vaughns JD, Koch G, Mikus G, van den Anker JN. Pharmacokinetics of fentanyl and its derivatives in children: a comprehensive review. Clin Pharmacokinet. 2018;57(2):125–149. doi:10.1007/s40262-017-0569-6
  • Aubrun F, Langeron O, Quesnel C, Coriat P, Riou B. Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration. Anesthesiology. 2003;98:1415–1421. doi:10.1097/00000542-200306000-00017
  • Hirschfeld G, Zernikow B, Kraemer N, et al. Development of Somatosensory perception in children: a Longitudinal QST-Study. Neuropediatrics. 2012;43(01):10–16. doi:10.1055/s-0032-1307450
  • Association of PaediatricAnaesthetists of Great Britain and Ireland. Good practice in postoperative and procedural pain management, 2nd edition. PaediatrAnaesth. 2012;22(Suppl 1):1–79. doi:10.1111/j.1460-9592.2012.03838.x
  • Dahmani S, Dupont H, Mantz J, Desmonts JM, Keita H. Predictive factors of early morphine requirements in the post-anaesthesia care unit (PACU). Br J Anaesth. 2001;87(3):385–389. doi:10.1093/bja/87.3.385
  • Fitzgerald M. The development of nociceptive circuits. Nat Rev Neurosci. 2005;6(7):507–520. doi:10.1038/nrn1701
  • Crews KR, Monte AA, Huddart R, et al. Clinical pharmacogenetics implementation consortium guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy. Clin Pharmacol Ther. 2021;110(4):888–896. doi:10.1002/cpt.2149
  • Bastami S, Gupta A, Zackrisson AL, Ahlner J, Osman A, Uppugunduri S. Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption. Basic Clin Pharmacol Toxicol. 2014;115(5):423–431. doi:10.1111/bcpt.12248
  • Lee MG, Kim HJ, Lee KH, Choi YS. The influence of genotype polymorphism on morphine analgesic effect for postoperative pain in children. Korean J Pain. 2016;29(1):34–39. doi:10.3344/kjp.2016.29.1.34
  • Gong XD, Wang JY, Liu F, et al. Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain. Asian Pac J Cancer Prev. 2013;14(5):2937–2943. doi:10.7314/apjcp.2013.14.5.2937
  • Chen Y, Chen Q, Cai C, et al. Effect of OPRM1/COMT gene polymorphisms on sufentanil labor analgesia: a cohort study based on propensity score matching. Pharmacogenomics. 2023;24(12):675–684. doi:10.2217/pgs-2023-0103
  • Umukoro NN, Aruldhas BW, Rossos R, Pawale D, Renschler JS, Sadhasivam S. Pharmacogenomics of oxycodone: a narrative literature review. Pharmacogenomics. 2021;22(5):275–290. doi:10.2217/pgs-2020-0143
  • Ofoegbu A, B. Ettienne E. Pharmacogenomics and morphine. J Clin Pharmacol. 2021;61(9):1149–1155. Erratum in: J Clin Pharmacol. 2023 Jun;63(6):747. doi:10.1002/jcph.1873
  • Zhang Y, Wang D, Johnson AD, Papp AC, Sadée W. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem. 2005;280(38):32618–32624. doi:10.1074/jbc.M504942200
  • Ren ZY, Xu XQ, Bao YP, et al. The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis. Pain Physician. 2015;18(2):131–152.
  • Coulbault L, Beaussier M, Verstuyft C, et al. Environmental and genetic factors associated with morphine response in the postoperative period. Clin Pharmacol Ther. 2006;79(4):316–324. doi:10.1016/j.clpt.2006.01.007
  • Howie SR. Blood sample volumes in child health research: review of safe limits. Bull World Health Organ. 2011;89(1):46–53. doi:10.2471/BLT.10.080010
  • Von Baeyer CL. Children’s self-report of pain intensity: what we know, where we are headed. Pain Res Manag. 2009;14(1):39–45. doi:10.1155/2009/259759
  • Mireskandari SM, Abulahrar N, Darabi ME, Rahimi I, Haji-Mohamadi F, Movafegh A. Comparison of the effect of fentanyl, sufentanil, alfentanil and remifentanil on cardiovascular response to tracheal intubation in children. Iran J Pediatr. 2011;21(2):173–180.
  • Wu WD, Wang Y, Fang YM, Zhou HY. Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery. Mol Diagn Ther. 2009;13(5):331–337. doi:10.1007/BF03256337
  • Oertel BG, Schmidt R, Schneider A, Geisslinger G, Lötsch J. The μ-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers. Pharmacogenet Genomics. 2006;16(9):625–636. doi:10.1097/01.fpc.0000220566.90466.a2
  • Chou WY, Wang CH, Liu PH, Liu CC, Tseng CC, Jawan B. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology. 2006;105(2):334–337. doi:10.1097/00000542-200608000-00016
  • Sadhasivam S, Chidambaran V, Olbrecht VA, et al. Genetics of pain perception, COMT and postoperative pain management in children. Pharmacogenomics. 2014;15(3):277–284. doi:10.2217/pgs.13.248
  • De Gregori M, Garbin G, De Gregori S, et al. Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain. Eur J Clin Pharmacol. 2013;69(9):1651–1658. doi:10.1007/s00228-013-1523-7
  • Hajj A, Peoc’h K, Laplanche JL, et al. Genotyping test with clinical factors: better management of acute postoperative pain? Int J Mol Sci. 2015;16(3):6298–6311. doi:10.3390/ijms16036298
  • Zernikow B, Wager J, Hechler T, et al. Characteristics of highly impaired children with severe chronic pain: a 5-year retrospective study on 2249 pediatric pain patients. BMC Pediatr. 2012;12(54). doi:10.1186/1471-2431-12-54
  • Avian A, Messerer B, Wünsch G, Weinberg A, Kiesling AS, Berghold A. Postoperative paediatric pain prevalence: a retrospective analysis in a university teaching hospital. Int J Nurs Stud. 2016;62:36–43. doi:10.1016/j.ijnurstu.2016.07.011
  • Chidambaran V, Mavi J, Esslinger H, et al. Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents. Pharmacogenomics J. 2015;15(3):255–262. doi:10.1038/tpj.2014.59
  • Mamie C, Rebsamen MC, Morris MA, Morabia A. First evidence of a polygenic susceptibility to pain in a pediatric cohort. AnesthAnalg. 2013;116(1):170–177. doi:10.1213/ANE.0b013e31826f0637
  • Cohen B, Tanios M, Koyuncu O, et al. Association between higher BMI and postoperative pain and opioid consumption in pediatric inpatients – a retrospective cohort study. J ClinAnesth. 2020;62(109729). doi:10.1016/j.jclinane.2020.109729
  • Zuberi AR, Townsend L, Patterson L, Zheng H, Berthoud HR. Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in mu-opioid receptor-deficient mice. Eur J Pharmacol. 2008;585(1):14–23. doi:10.1016/j.ejphar.2008.01.047
  • Pucci M, Micioni Di Bonaventura MV, Vezzoli V, et al. Preclinical and clinical evidence for a distinct regulation of mu opioid and type 1 cannabinoid receptor genes expression in obesity. Front Genet. 2019;10:523. doi:10.3389/fgene.2019.00523
  • Haghighi A, Melka MG, Bernard M, et al. Opioid receptor mu 1 gene, fat intake and obesity in adolescence. Mol Psychiatry. 2014;19(1):63–68. doi:10.1038/mp.2012.179
  • Kim KM. Opioid pharmacogenetics in anesthesia and pain management. Anesth Pain Med. 2015;10(2):65–76. doi:10.17085/apm.2015.10.2.65
  • Lee SH, Kim JD, Park SA, Oh CS, Kim SH. Effects of µ-Opioid receptor gene polymorphism on postoperative nausea and vomiting in patients undergoing general anesthesia with remifentanil: double blinded randomized trial. J Korean Med Sci. 2015;30(5):651–657. doi:10.3346/jkms.2015.30.5.651
  • Campa D, Gioia A, Tomei A, Poli P, Barale R. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther. 2008;83(4):559–566. doi:10.1038/sj.clpt.6100385
  • Klepstad P, Rakvåg TT, Kaasa S, et al. The 118 A>G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand. 2004;48(10):1232–1239. doi:10.1111/j.1399-6576.2004.00517.x
  • Chou W-Y, Yang L-C, H-F L, et al. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand. 2006;50(7):787–792. doi:10.1111/j.1399-6576.2006.01058.x
  • Klepstad P, Fladvad T, Skorpen F, et al. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain. 2011;152(5):1139–1145. doi:10.1016/j.pain.2011.01.040